Saltar al contenido

Enovis Corp (ENOV) stock: revenue, earnings & dividend

Enovis Corp (ENOV, NYSE): revenue, earnings, dividend and balance sheet from official SEC filings.

Stock screener ENOV · NYSE Medizintechnik & Messgeräte US-TX

Key figures

Fiscal year
2025
Revenue
2.25 bn $
Revenue growth
6.7 %
Revenue growth 5y (p.a.)
14.9 %
Net income
-1.18 bn $
Net margin
-52.7 %
Operating margin
-50 %
Earnings per share (diluted)
-20.75 $
Dividend per share
–
Payout ratio
–
Consecutive dividend years
–
Consecutive dividend raises
–
Dividend growth 5y (p.a.)
–
Total assets
3.83 bn $
Equity
1.49 bn $
Equity ratio
38.9 %
Return on equity
-79.5 %
Cash
36.4 m $
Operating cash flow
217 m $
Free cash flow
19.9 m $
Shares outstanding
57,694,806

History

Revenue by fiscal year

2016 3.19 bn $
2017 3.3 bn $
2018 3.67 bn $
2019 3.33 bn $
2020 1.12 bn $
2021 1.43 bn $
2022 1.56 bn $
2023 1.71 bn $
2024 2.11 bn $
2025 2.25 bn $

Net income by fiscal year

2016 128 m $
2017 151 m $
2018 140 m $
2019 -527.65 m $
2020 42.6 m $
2021 71.7 m $
2022 -13.29 m $
2023 -33.26 m $
2024 -825.49 m $
2025 -1.18 bn $
YearRevenueNet incomeEPSDividend per shareOperating cash flow
20252.25 bn $-1.18 bn $-20.75 $–217 m $
20242.11 bn $-825.49 m $-14.93 $–114 m $
20231.71 bn $-33.26 m $-0.61 $–135 m $
20221.56 bn $-13.29 m $-0.25 $–-55.86 m $
20211.43 bn $71.7 m $1.40 $–356 m $
20201.12 bn $42.6 m $0.93 $–302 m $
20193.33 bn $-527.65 m $-3.89 $–131 m $
20183.67 bn $140 m $1.16 $–226 m $
20173.3 bn $151 m $1.22 $–219 m $
20163.19 bn $128 m $1.04 $–247 m $

Data from XBRL filings at the SEC, processed automatically, no guarantee. Not investment advice. All filings at the SEC (EDGAR)